Roy Winston

2021

In 2021, Roy Winston earned a total compensation of $2.5M as Chief Medical Officer at Pacira Pharmaceuticals, a 11% increase compared to previous year.

Compensation breakdown

Bonus$275,000
Non-Equity Incentive Plan$184,602
Option Awards$760,931
Salary$515,000
Stock Awards$721,470
Other$22,336
Total$2,479,339

Winston received $760.9K in option awards, accounting for 31% of the total pay in 2021.

Winston also received $275K in bonus, $184.6K in non-equity incentive plan, $515K in salary, $721.5K in stock awards and $22.3K in other compensation.

Rankings

In 2021, Roy Winston's compensation ranked 5,178th out of 12,406 executives tracked by ExecPay. In other words, Winston earned more than 58.3% of executives.

ClassificationRankingPercentile
All
5,178
out of 12,406
58th
Division
Manufacturing
2,175
out of 5,494
60th
Major group
Chemicals And Allied Products
937
out of 2,369
60th
Industry group
Drugs
837
out of 2,090
60th
Industry
Pharmaceutical Preparations
600
out of 1,537
61st

Pay ratio

Roy Winston's Pay$2,479,339
Median Employee's Pay$199,797
Pay Ratio

12

to 1

In 2021, the annual total compensation of Roy Winston was $2,479,339.

The annual total compensation of the median employee at Pacira Pharmaceuticals was $199,797.

The ratio of Roy Winston's pay to the pay of median employee was therefore 12 to one.

Source: SEC filing on April 22, 2022.

Winston's colleagues

We found four more compensation records of executives who worked with Roy Winston at Pacira Pharmaceuticals in 2021.

2021

David Stack

Pacira Pharmaceuticals

Chief Executive Officer

2021

Jonathan Slonin

Pacira Pharmaceuticals

Chief Clinical Officer

2021

Max Reinhardt

Pacira Pharmaceuticals

President, Rest of World

2021

Charles Reinhart

Pacira Pharmaceuticals

Chief Financial Officer

News

You may also like